
Major Breakthrough Offers New Hope for Advanced Prostate Cancer Patients
A groundbreaking 'holy grail' cancer therapy involving tumor freezing and immunotherapy drugs shows promising results in treating terminal prostate cancer, with over half of patients experiencing complete remission and most surviving beyond 14 months, offering new hope for advanced cases.

